Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids

Cholesterol is an essential lipid in vertebrates, but excess blood cholesterol promotes atherosclerosis. In the liver, cholesterol is metabolized to bile acids by cytochrome P450, family 7, subfamily a, polypeptide 1 (CYP7A1), the transcription of which is negatively regulated by the ERK pathway. Fi...

Full description

Bibliographic Details
Main Authors: Ryoma Tagawa, Masaki Kobayashi, Misako Sakurai, Maho Yoshida, Hiroki Kaneko, Yuhei Mizunoe, Yuka Nozaki, Naoyuki Okita, Yuka Sudo, Yoshikazu Higami
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/3/1793
_version_ 1797487167227822080
author Ryoma Tagawa
Masaki Kobayashi
Misako Sakurai
Maho Yoshida
Hiroki Kaneko
Yuhei Mizunoe
Yuka Nozaki
Naoyuki Okita
Yuka Sudo
Yoshikazu Higami
author_facet Ryoma Tagawa
Masaki Kobayashi
Misako Sakurai
Maho Yoshida
Hiroki Kaneko
Yuhei Mizunoe
Yuka Nozaki
Naoyuki Okita
Yuka Sudo
Yoshikazu Higami
author_sort Ryoma Tagawa
collection DOAJ
description Cholesterol is an essential lipid in vertebrates, but excess blood cholesterol promotes atherosclerosis. In the liver, cholesterol is metabolized to bile acids by cytochrome P450, family 7, subfamily a, polypeptide 1 (CYP7A1), the transcription of which is negatively regulated by the ERK pathway. Fibroblast growth factor 21 (FGF21), a hepatokine, induces ERK phosphorylation and suppresses <i>Cyp7a1</i> transcription. Taurine, a sulfur-containing amino acid, reportedly promotes cholesterol metabolism and lowers blood and hepatic cholesterol levels. However, the influence of long-term feeding of taurine on cholesterol levels and metabolism remains unclear. Here, to evaluate the more chronic effects of taurine on cholesterol levels, we analyzed mice fed a taurine-rich diet for 14–16 weeks. Long-term feeding of taurine lowered plasma cholesterol and bile acids without significantly changing other metabolic parameters, but hardly affected these levels in the liver. Moreover, taurine upregulated <i>Cyp7a1</i> levels, while downregulated phosphorylated ERK and <i>Fgf21</i> levels in the liver. Likewise, taurine-treated Hepa1-6 cells, a mouse hepatocyte line, exhibited downregulated <i>Fgf21</i> levels and upregulated promoter activity of <i>Cyp7a1</i>. These results indicate that taurine promotes cholesterol metabolism by suppressing the FGF21/ERK pathway followed by upregulating <i>Cyp7a1</i> expression. Collectively, this study shows that long-term feeding of taurine lowers both plasma cholesterol and bile acids, reinforcing that taurine effectively prevents hypercholesterolemia.
first_indexed 2024-03-09T23:43:43Z
format Article
id doaj.art-4df88fd97b354361aa031b2b69e2a865
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:43:43Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4df88fd97b354361aa031b2b69e2a8652023-11-23T16:46:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-02-01233179310.3390/ijms23031793Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile AcidsRyoma Tagawa0Masaki Kobayashi1Misako Sakurai2Maho Yoshida3Hiroki Kaneko4Yuhei Mizunoe5Yuka Nozaki6Naoyuki Okita7Yuka Sudo8Yoshikazu Higami9Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDepartment of Internal Medicine Endocrinology and Metabolism, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDivision of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Yamaguchi 756-0884, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanDepartment of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, JapanCholesterol is an essential lipid in vertebrates, but excess blood cholesterol promotes atherosclerosis. In the liver, cholesterol is metabolized to bile acids by cytochrome P450, family 7, subfamily a, polypeptide 1 (CYP7A1), the transcription of which is negatively regulated by the ERK pathway. Fibroblast growth factor 21 (FGF21), a hepatokine, induces ERK phosphorylation and suppresses <i>Cyp7a1</i> transcription. Taurine, a sulfur-containing amino acid, reportedly promotes cholesterol metabolism and lowers blood and hepatic cholesterol levels. However, the influence of long-term feeding of taurine on cholesterol levels and metabolism remains unclear. Here, to evaluate the more chronic effects of taurine on cholesterol levels, we analyzed mice fed a taurine-rich diet for 14–16 weeks. Long-term feeding of taurine lowered plasma cholesterol and bile acids without significantly changing other metabolic parameters, but hardly affected these levels in the liver. Moreover, taurine upregulated <i>Cyp7a1</i> levels, while downregulated phosphorylated ERK and <i>Fgf21</i> levels in the liver. Likewise, taurine-treated Hepa1-6 cells, a mouse hepatocyte line, exhibited downregulated <i>Fgf21</i> levels and upregulated promoter activity of <i>Cyp7a1</i>. These results indicate that taurine promotes cholesterol metabolism by suppressing the FGF21/ERK pathway followed by upregulating <i>Cyp7a1</i> expression. Collectively, this study shows that long-term feeding of taurine lowers both plasma cholesterol and bile acids, reinforcing that taurine effectively prevents hypercholesterolemia.https://www.mdpi.com/1422-0067/23/3/1793taurinecholesterolbile acidFGF21ERKCYP7A1
spellingShingle Ryoma Tagawa
Masaki Kobayashi
Misako Sakurai
Maho Yoshida
Hiroki Kaneko
Yuhei Mizunoe
Yuka Nozaki
Naoyuki Okita
Yuka Sudo
Yoshikazu Higami
Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
International Journal of Molecular Sciences
taurine
cholesterol
bile acid
FGF21
ERK
CYP7A1
title Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
title_full Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
title_fullStr Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
title_full_unstemmed Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
title_short Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
title_sort long term dietary taurine lowers plasma levels of cholesterol and bile acids
topic taurine
cholesterol
bile acid
FGF21
ERK
CYP7A1
url https://www.mdpi.com/1422-0067/23/3/1793
work_keys_str_mv AT ryomatagawa longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT masakikobayashi longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT misakosakurai longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT mahoyoshida longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT hirokikaneko longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT yuheimizunoe longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT yukanozaki longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT naoyukiokita longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT yukasudo longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids
AT yoshikazuhigami longtermdietarytaurinelowersplasmalevelsofcholesterolandbileacids